R&D News | pharmaphorum

News

euro notes and tablets, symbol photo for costs of medicines and health insurance.

European VCs ‘actively seeking new healthcare investments’

The disruption caused by the coronavirus crisis hasn’t dampened the enthusiasm of European venture capitalists to make funding available to healthcare companies, says a ne

News

AZ scales up COVID-19 vaccine effort after $1bn US investmen...

AstraZeneca has said that it will be able to produce a billion doses of its potential COVID-19 vaccine by 2021 after receiving more than $1 billion from the US government to support develop

News

Gilead and Galapagos shares hit as filgotinib disappoints

Gilead and Galapagos' late-stage trial of their ulcerative colitis drug filgotinib has hit its target – but shares in both companies were down after data suggested the drug may struggle for

News

Blood sample with respiratory coronavirus positive

Biosig cleared to test merimepodib plus remdesivir in COVID-...

US biotech BioSig Technologies’ subsidiary ViralClear has been cleared by the FDA to start a phase 2 trial of its antiviral drug merimepodib in patients who are severely ill wi

News

Moderna to raise $1.34bn for late-stage COVID-19 vaccine tri...

Moderna’s COVID-19 vaccine has produced a strong immune response in early trials – but will it be able to prevent infections on a large scale?

News

Canada joins COVID-19 vaccine race after okaying trials of f...

The race is on to find a vaccine for COVID-19 and Canada’s government may have taken the lead after its national drug regulator cleared a plan to begin studying the front-running candidate.

European VCs ‘actively seeking new healthcare investments’

AZ scales up COVID-19 vaccine effort after $1bn US investmen...

Gilead and Galapagos shares hit as filgotinib disappoints

Biosig cleared to test merimepodib plus remdesivir in COVID-...

Moderna to raise $1.34bn for late-stage COVID-19 vaccine tri...

Canada joins COVID-19 vaccine race after okaying trials of f...

Third Rock in $2bn drug-hunting pact with China's Funnel

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks